Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Understand Acceptability of Long-Acting Pre-Exposure Prophylaxis for HIV-1 Prevention in Transgender and Gender Diverse Populations in Texas

NCT05044286 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT05044286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05044286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Understand Acceptability of Long-Acting Pre-Exposure Prophylaxis for HIV-1 Prevention in Transgender and Gender Diverse Populations in Texas
Lead sponsor
University of Texas at Austin
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
August 31, 2023
Enrollment
565 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection